Replace or augment traditional and subjective sleep assessment tools with continuous, objective 24-hour sleep/wake data collected from the participant’s own home.
Objective, Reliable In-Home Sleep Assessment
ActiGraph’s innovative actigraphy monitoring system delivers 24-hour, real-world information about sleep/wake behavior, circadian rhythms, and daytime physical activity. With its ability to capture high quality continuous actigraphy data for weeks at a time, the ActiGraph system is a cost-effective and noninvasive in-home solution that offers a level of accuracy and reliability that cannot be achieved through subjective patient reports.
Validated, Innovative Wearable Technology
ActiGraph's wearable actigraphy monitors are among the most widely used and extensively validated devices of their kind. Our clients benefit from a wide variety of innovative features designed to optimize research capabilities, reduce participant burden, and improve overall study efficiency and cost-effectiveness.
U.S. federal law restricts this device to sale by or on the order of a physician.
See how ActiGraph compares to PSG
Advanced Analytics & Near Real-Time Data
ActiGraph’s flagship ActiLife software platform was developed in collaboration with the scientific community to deliver raw e-source data and a variety of sleep/wake and daytime activity measures derived from validated, publicly available industry standard algorithms.
The cloud-based CentrePoint platform leverages mobile, wireless, and cellular technologies to provide near real-time access to participant sleep/wake data, wear compliance details, and overall study progress across multiple research or clinical sites.
Appearing in more than 17,000 published scientific papers to date, ActiGraph is the most experienced and widely used actigraphy monitoring system in the world. Collecting your study data with ActiGraph solutions ensures comparability to benchmark population data from numerous large scale epidemiology studies conducted around the world, including the U.S. National Health and Nutrition Examination Survey (NHANES), the Raine Study, the Women’s Health Study, and the NAKO German National Cohort Study.
View a selection of ActiGraph sleep studies
Actigraphy Reimbursement Information
Updated May 24, 2011
Category 1 (CPT) Code 95803 has been approved for the use of actigraphy.
Code 95803 Description: Actigraph testing, recording, analysis, interpretation, and report (a minimum of 72 hours to 14 consecutive days of recording, requires a patient to wear a home monitor for 24 hours a day for 3 to 14 days)
In 2011 Medicare increased its reimbursement for the technical component of the test by 56% over the previous years’ amount. Medicare now pays approximately $115 for the technical component and $46.89 for the professional component, yielding a global Medicare reimbursement for actigraphy of about $162 per test.*
Actigraphy (95803) was released under Contract Carrier Pricing; therefore, coverage guidelines have not yet been issued by the Centers for Medicare and Medicaid Services (CMS) and current coverage/reimbursement varies by jurisdiction.
All CMS sleep related codes have been under review (including actigraphy) since early 2010. We are hopeful and it is anticipated that a revised reimbursement schedule will be released in late fall with coverage guidelines commencing in January of 2011.
Claims for other ancillary services, such as Evaluation and Management (E&M) or replacement supplies and professional/technical components may be eligible for reimbursement in addition to the actigraphy service, but it is not completely certain at this time.
Documentation of patient sleep complaints may be requested by payers to verify the medical necessity of actigraphy testing. Actigraphy may be useful for the evaluation of conditions such as insomnia/hypersomnia, daytime sleepiness, periodic leg movement disorder, and CPAP compliance. Many have found it helpful to verify payer policy and coverage requirements prior to providing actigraphy services. However, utilizing the appeals process post a rejection for reimbursement, has also been reported with moderate success.
*Medicare information furnished courtesy of Sleep Review Magazine. For more information, contact the ActiGraph Sales Department.